Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kensuke Yoshida

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Anticancer Research|February 27, 2026
Diuretic Administration for Vomiting During Concurrent Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective StudyNaoya Tonomura, Kensuke Yoshida, Hajime Morita, et al.
In Vivo (Athens, Greece)|June 30, 2026
Olanzapine Use and Vomiting Incidence in Chemotherapy-receiving Patients With Cervical Cancer: Multicenter Post Hoc AnalysisYusuke Kawamura, Kensuke Yoshida, Hajime Morita, et al.
Anticancer Research|June 29, 2026
Association Between Brachytherapy and Acute Diarrhea During Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective StudyMasaki Nakai, Kensuke Yoshida, Hajime Morita, et al.
Plos One|April 8, 2026
Prevention of oral mucositis in patients undergoing cancer chemotherapy using betamethasone mouthwash: A multicenter randomized controlled trial protocolSakiko Soutome, Tomofumi Hamada, Hiromi Nishi, et al.
Scientific Reports|October 28, 2025
Development and validation of predictive model for emesis in cervical cancer patients receiving concurrent chemoradiotherapy based on multi-institutional retrospective studyKensuke Yoshida, Hajime Morita, Masaki Nakai, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Anticancer Research|February 27, 2026
Diuretic Administration for Vomiting During Concurrent Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective StudyNaoya Tonomura, Kensuke Yoshida, Hajime Morita, et al.
In Vivo (Athens, Greece)|June 30, 2026
Olanzapine Use and Vomiting Incidence in Chemotherapy-receiving Patients With Cervical Cancer: Multicenter Post Hoc AnalysisYusuke Kawamura, Kensuke Yoshida, Hajime Morita, et al.
Anticancer Research|June 29, 2026
Association Between Brachytherapy and Acute Diarrhea During Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective StudyMasaki Nakai, Kensuke Yoshida, Hajime Morita, et al.
Plos One|April 8, 2026
Prevention of oral mucositis in patients undergoing cancer chemotherapy using betamethasone mouthwash: A multicenter randomized controlled trial protocolSakiko Soutome, Tomofumi Hamada, Hiromi Nishi, et al.
Scientific Reports|October 28, 2025
Development and validation of predictive model for emesis in cervical cancer patients receiving concurrent chemoradiotherapy based on multi-institutional retrospective studyKensuke Yoshida, Hajime Morita, Masaki Nakai, et al.
Pageof 4